Ultima Genomics, Genome Insight partner on low-cost whole-genome sequencing for cancer patients (Genomeweb)
"Ultima Genomics and Genome Insight said on Monday that they are collaborating to develop affordable whole-genome sequencing testing for cancer patients...As part of the agreement, Genome Insight will join the early-access program for Ultima's high-throughput sequencing platform, the UG 100, and optimize its whole-genome bioinformatics algorithm for cancer analysis using Ultima's sequencing technology."